Kliniske forsøg med Anti-PD1/PDL1 antistof
I alt 230 resultater
-
Merck Sharp & Dohme LLCRekrutteringIkke-småcellet lungekræft | Faste tumorer | Programmeret celledød-1 (PD1, PD-1) | Programmeret celledød 1 Ligand 1 (PDL1, PD-L1) | Programmeret celledød 1 ligand 2 (PDL2, PD-L2)Japan
-
Sun Yat-sen UniversityRekrutteringAvanceret hepatocellulært karcinom | Bevacizumab | Anti-PD1/PDL1 antistofKina
-
University of ZurichIncyte CorporationIkke rekrutterer endnuEksantem | Lichenoid hududslæt under anti-PD1-tumorterapi
-
Sun Yat-sen UniversitySecond Affiliated Hospital of Guangzhou Medical UniversityAfsluttetLeversygdomme | Hepatocellulært karcinom | Anti-PD1 antistofKina
-
Shanghai Zhongshan HospitalRenJi Hospital; Xinhua Hospital, Shanghai Jiao Tong University School of... og andre samarbejdspartnereRekrutteringIntrahepatisk cholangiocarcinom | Lenvatinib | PD1 antistof | Gemox kemoterapiKina
-
Chinese PLA General HospitalRekrutteringAvanceret gastroøsofagealt adenokarcinom | Første linje terapi | PDL1 CPS < 5Kina
-
University Hospital, MontpellierAfsluttetPatienter, der modtager anti-PD-1 eller Anti-PD-L1 immunterapierFrankrig
-
Second Affiliated Hospital, School of Medicine,...First People's Hospital of HangzhouRekrutteringAkut myokardieinfarkt | PD1Kina
-
Chinese PLA General HospitalRekrutteringHodgkin lymfom | Anti-PD-1 antistof resistentKina
-
Sohag UniversityIkke rekrutterer endnuPDL1 - kolorektalt karcinom
-
Zhejiang Cancer HospitalAktiv, ikke rekrutterendeIkke-småcellet lungekræft | PDL1-genmutationKina
-
West China HospitalFirst Affiliated Hospital of Chongqing Medical University; Sichuan Cancer... og andre samarbejdspartnereRekrutteringEndetarmskræft | Strålebehandling | Anti-PD-1 antistof | MSI-H | Mmr MangelKina
-
Targovax OyAfsluttetAvanceret eller uoperabelt melanom, der skrider frem efter PD1-blokadeForenede Stater, Norge
-
Peking Union Medical College HospitalRekrutteringAnlotinib | Anti-PD-1 antistof | Avanceret kræft i bugspytkirtlenKina
-
Lei LiAfsluttetKemoterapi | Tilbagevendende cervikal karcinom | Immunterapi | Anti-PD-1 antistof | Vedvarende avanceret cervikal karcinomKina
-
Zhejiang Cancer HospitalIkke rekrutterer endnuMavekræft, HIPEC, Anti-PD-1 antistof Camrelizumab (SHR-1210), kemoterapi og kirurgiKina
-
Second Affiliated Hospital of Guangzhou Medical...Guangdong Zhaotai InVivo Biomedicine Co. Ltd.RekrutteringBrystkræft | Lungekræft | Hjerne svulst | Colo-rektal cancer | Leverkræft | Solid tumor, voksen | CTLA4 | PD1Kina
-
Radiopharm Theranostics, LtdRekrutteringIkke småcellet lungekræft | PDL1-genmutationAustralien
-
Lei LiRekrutteringKemoterapi | Tilbagevendende cervikal karcinom | Immune Checkpoint-hæmmere | Anti-PD-1 antistof | Vedvarende avanceret cervikal karcinom | Albumin-bundet PaclitaxelKina
-
Shanghai Jiao Tong University School of MedicineRekrutteringOralt planocellulært karcinom | Anti-PD-1 | Neoadjvant terapi | Anti-VEGFRKina
-
Beijing Friendship HospitalAfsluttetGaldevejskræft | Capecitabin | Målrettet molekylær terapi | Anti-PD-1 terapiKina
-
Ascendis Pharma Oncology Division A/SRekrutteringAvanceret solid tumor | Metastatisk fast tumor | Platin-resistent kræft i æggestokkene | Lokalt avanceret solid tumor | Post Anti-PD-1 melanom | 2L+ livmoderhalskræft | Neoadjuverende melanom | Neoadjuverende ikke-småcellet lungekræft | Post Anti-PD-(L)1 ikke-småcellet lungekræft | Post Anti-PD-(L)1 småcellet...Forenede Stater, Australien, Korea, Republikken
-
Anhui Provincial HospitalIkke rekrutterer endnuHøje titre af anti-HLA-antistof (MFI ≥5000)Kina
-
Sun Yat-sen UniversityRekrutteringImmunterapi | DMMR tyktarmskræft | Anti PD-1Kina
-
Assistance Publique - Hôpitaux de ParisEtablissement Français du Sang (Nouvelle Aquitaine)RekrutteringBloddonorer | Anti-HLA antistofFrankrig
-
Xencor, Inc.ICON plcAfsluttetMelanom | Nyrecellekarcinom | Livmoderhalskræft | Nasopharyngealt karcinom | Småcellet lungekarcinom | Hepatocellulært karcinom | Thymisk karcinom | Thymom | Ikke-småcellet lungekarcinom | Mesotheliom | Planocellulært karcinom i hoved og hals | Cholangiocarcinom | Brystkarcinom | Æggelederkarcinom | Endometriekarcinom | Urothelialt... og andre forholdForenede Stater
-
The Second Affiliated Hospital of Chongqing Medical...Guizhou Provincial People's Hospital; The Affiliated Hospital Of Southwest...Ikke rekrutterer endnuKronisk hepatitis b | Anti-PD-1 antistofKina
-
The First Hospital of Jilin UniversityIkke rekrutterer endnuLokalt avanceret endetarmskræft | Anti-PD-1 | Total Neoadjuverende behandlingKina
-
Nanjing University School of MedicineAfsluttetVaskulitis | Anti-neutrofilt cytoplasmatisk antistofKina
-
The Second Affiliated Hospital of Chongqing Medical...Guizhou Provincial People's Hospital; The Affiliated Hospital Of Southwest...Ikke rekrutterer endnuKronisk hepatitis b | Anti-PD-1 antistof | Peg-IFNaKina
-
Università Politecnica delle MarcheIkke rekrutterer endnuLymfom | Lungeneoplasmer | Tuberkulose | EGF-R positiv ikke-småcellet lungekræft | Sarcoidose | Mediastinal lymfadenopati | Hilar lymfadenopati | ROS1 genmutation | PDL1-genmutation | ALK TranslokationItalien
-
Lei LiUkendtKemoterapi | Tilbagevendende cervikal karcinom | Bivirkningshændelse | Cervikal neuroendokrin karcinom | Objektiv svarprocent | Avanceret livmoderhalskræft | Anti-pd-1 antistofKina
-
Shanghai Jiao Tong University School of MedicineRekrutteringKemoterapi | Oralt planocellulært karcinom | Anti-PD-1 | Neoadjvant terapiKina
-
Medical University of GrazAfsluttetAnti-SARS-CoV-2 antistofresponsØstrig
-
Yale UniversityMerck Sharp & Dohme LLCRekrutteringMelanom | Nyrecellekarcinom | Metastatisk melanom | Hjernemetastaser | Pembrolizumab | Lenvatinib | PD1/PD-L1 ErfarenForenede Stater
-
AmgenAfsluttetAnti-neutrofil cytoplasmatisk antistof-associeret vaskulitisForenede Stater
-
AmgenAfsluttetAnti-neutrofil cytoplasmatisk antistof-associeret vaskulitisJapan
-
AmgenAfsluttetAnti-neutrofil cytoplasmatisk antistof-associeret vaskulitisForenede Stater
-
AmgenRekrutteringAntineutrofil cytoplasmatisk antistof-associeret vaskulitisForenede Stater
-
Assistance Publique - Hôpitaux de ParisURC-CIC Paris Descartes Necker CochinIkke rekrutterer endnuGranulomatose med polyangiitis | Anti-neutrofil cytoplasmatisk antistof-associeret vaskulitisFrankrig
-
Ningbo Cancer HospitalUkendtAvancerede maligniteter | PD-1 antistof | CAR-T cellerKina
-
Shanghai International Medical CenterUkendtAvanceret solid tumor | PD-1 antistof | CAR-T cellerKina
-
AmgenAfsluttetAnti-neutrofil cytoplasmatisk antistof-associeret vaskulitisForenede Stater
-
Mårten SegelmarkHansa Biopharma ABAfsluttetAnti-glomerulær kældermembran-antistofsygdomØstrig, Tjekkiet, Danmark, Frankrig, Sverige
-
Staidson (Beijing) Biopharmaceuticals Co., LtdAfsluttetAntineutrofil cytoplasmatisk antistof associeret vaskulitisForenede Stater
-
University of North Carolina, Chapel HillNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) og andre samarbejdspartnereTrukket tilbageAnti-neutrofil cytoplasmatisk antistof-associeret vaskulitisForenede Stater
-
Second Affiliated Hospital, School of Medicine,...RekrutteringLivmoderhalskræft | Neoadjuverende kemoterapi | Anti-PD-1 | Neoadjuverende immunterapiKina
-
Beijing Friendship HospitalIkke rekrutterer endnu
-
University of North Carolina, Chapel HillNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Trukket tilbageAnti-neutrofil cytoplasmatisk antistof-associeret vaskulitisForenede Stater
-
University Hospital, BrestRekruttering